Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 88-95

  Alemany, Laia ^a,b   De Sanjosé, Silvia ^a,b   Tous, Sara ^a   Quint, Wim ^c   Vallejos, Carlos ^d   Shin, Hai Rim ^e   Bravo, Luis E ^f   Alonso, Patricia ^g   Lima, Marcus A ^h   Guimerà, Núria ^c   Klaustermeier, Joellen ^a,b   Llombart Bosch, Antonio ⁱ   Kasamatsu, Elena ^j   Tatti, Silvio A ^k   Felix, Ana ^l   Molina, Carla ^m   Velasco, Julio ⁿ   Lloveras, Belen ^o   Clavero, Omar ^a   Lerma, Enrique ^p   Laco, Jan ^q   Bravo, Ignacio G ^a   Guarch, Rosa ^r   Pelayo, Adela ^s   Ordi, Jaume ^t   Andújar, Miguel ^u   Sanchez, Gloria I ^v   Castellsagué, Xavier ^a   Muñoz, Nubia ^w   Bosch, F Xavier ^a   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c DDL DIAGNOSTIC LABORATORY   (Netherlands)

^d INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^e National Cancer Center   (South Korea)

^f UNIVERSIDAD DEL VALLE   (Colombia)

^g UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^h Laboratório de Anatomia Patológica e Citologia Associação de Combate Ao Câncer Do Brasil Central Hospital Dr Hélio Angotti   (Brazil)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

^j Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de Asuncion   (Paraguay)

^k HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^l INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^m UNIVERSITY OF CHILE   (Chile)

ⁿ HOSPITAL SAN AGUSTÍN   (Spain)

^o HOSPITAL DEL MAR   (Spain)

^p HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^q CHARLES UNIVERSITY   (Czech Republic)

^r Universidad Pública de Navarra   (Spain)

^s HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^t HOSPITAL CLÍNIC   (Spain)

^u HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^v UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^w Instituto Nacional de Cancerología   (Colombia)

more..

Author keywords

cervical cancer; human papillomavirus; time trends; types

Indexed keywords

CERVICAL CANCER; HUMAN PAPILLOMAVIRUS; TIME TRENDS; TYPES;

ADULT; AGED; ASIA; CENTRAL AMERICA; DNA, VIRAL; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84899442178     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28636     Document Type: Article

References (29)

1. Schiller JT, Castellsagué X, Garland SM,. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30 (Suppl 5): F123-38.
2. Dillner J, Arbyn M, Dillner L,. Translational mini-review series on vaccines: monitoring of human papillomavirus vaccination. Clin Exp Immunol 2007; 148: 199-207.
3. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
4. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in a restrospective cross-sectional study on 10,575 cases of invasive cervical cancer worldwide. Lancet Oncol 2010; 11: 1048-56.
5. Thompson CH, Rose BR, Cossart YE,. Detection of HPV DNA in archival specimens of cervical cancer using in situ hybridisation and the polymerase chain reaction. J Med Virol 1992; 36: 54-9.
6. Wheeler CM, Hunt WC, Joste NE, et al. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009; 101: 475-87.
7. Bertelsen BI, Kugarajh K, Skar R, et al. HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing. Virchows Arch 2006; 449: 141-7.
8. Ivansson EL, Gustavsson IM, Wilander E, et al. Temporal trends over 3 decades and intrafamilial clustering of HPV types in Swedish patients with cervical cancer in situ. Int J Cancer 2009; 125: 2930-5.
9. Sigurdsson K, Taddeo FJ, Benediktsdottir KR, et al. HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study. Int J Cancer 2007; 121: 2682-7.
10. Chan PK, Ho WC, Yu MY, et al. Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades. Int J Cancer 2009; 125: 1671-7.
11. Tavassoli FA, Devilee P, eds. World health organization classification of tumours, pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
12. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human Papillomaviruses. Am J Pathol 1998; 153: 1731-9.
13. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-17.
14. Geraets D, Alemany L, Guimera N, et al. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol 2012; 228: 534-43.
15. Wentzensen N, Schiffman M, Dunn T, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 2009; 125: 2151-8.
16. Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 1611-22.
17. Rector A, Lemey P, Tachezy R, et al. Ancient papillomavirus-host co-speciation in Felidae. Genome Biol 2007; 8: R57.
18. Bernard HU, Calleja-Macias IE, Dunn ST,. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006; 118: 1071-6.
19. Bravo IG, de Sanjosé S, Gottschling M,. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol 2010; 18: 432-8.
20. Laukkanen P, Koskela P, Pukkala E, et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003; 84: 2105-9.
21. Clifford GM, Gonçalves MA, Franceschi S,; HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20: 2337-44.
22. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536-45.
23. Bray F, Carstensen B, Møller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005; 14: 2191-9.
24. Tota JE, Ramanakumar AV, Jiang M, et al. Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol 2013; 178: 625-34.
25. Palmroth J, Merikukka M, Paavonen J, et al. Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination. Int J Cancer 2012; 131: 2832-8.
26. Ault KA, Joura EA, Kjaer SK, et al. FUTURE I and II Study Group. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. Int J Cancer 2011; 128: 1344-53.
27. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-85.
28. Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-13.
29. Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010; 102: 1478-88.